Literature DB >> 4296427

Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs.

A M Barrett, J M Thorp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4296427      PMCID： PMC1570194          DOI： 10.1111/j.1476-5381.1968.tb00980.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  17 in total

1.  AN EXPERIMENTAL APPROACH TO THE PROBLEM OF DISORDERED LIPID METABOLISM.

Authors:  J M THORP
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

2.  A COMPARISON OF THE EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE AND NICOTINIC ACID ON PLASMA FREE FATTY ACIDS.

Authors:  C H DUNCAN; M M BEST; G L ROBERTSON
Journal:  Lancet       Date:  1965-01-23       Impact factor: 79.321

3.  REDUCTION OF SERUM TRIGLYCERIDES AND CHOLESTEROL BY ETHYL P-CHLOROPHENOXY-ISOBUTYRATE (CPIB).

Authors:  M M BEST; C H DUNCAN
Journal:  Am J Cardiol       Date:  1965-02       Impact factor: 2.778

4.  Role of the pituitary and the adrenal in the mobilization of free fatty acids and lipoproteins.

Authors:  E SHAFRIR; K E SUSSMAN; D STEINBERG
Journal:  J Lipid Res       Date:  1960-10       Impact factor: 5.922

5.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

6.  Effect of ethylchlorophenoxyisobutyrate on weight, plasma volume, total body-water, and free fatty acids.

Authors:  D C Macmillan; M F Oliver; J D Simpson; P Tothill
Journal:  Lancet       Date:  1965-11-06       Impact factor: 79.321

7.  The role of plasma free fatty acids in the elevation of plasma cholesterol and phospholipids produced by adrenaline.

Authors:  A M Barrett
Journal:  J Endocrinol       Date:  1966-11       Impact factor: 4.286

8.  Feedback inhibition of key glycolytic enzymes in liver: action of free fatty acids.

Authors:  G Weber; H J Convery; M A Lea; N B Stamm
Journal:  Science       Date:  1966-12-09       Impact factor: 47.728

9.  Changes in the weight and composition of the liver in the rat, dog and monkey treated with ethyl chlorophenoxyisobutyrate.

Authors:  D S Platt; J M Thorp
Journal:  Biochem Pharmacol       Date:  1966-07       Impact factor: 5.858

10.  FURTHER OBSERVATIONS ON THE EFFECTS OF ATROMID AND OF ETHYL CHLOROPHENOXYISOBUTYRATE ON SERUM LIPID LEVELS.

Authors:  M F OLIVER
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec
View more
  12 in total

1.  Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

Authors:  M A D'Costa; A Angel
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

2.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

Authors: 
Journal:  Br Heart J       Date:  1978-10

Review 3.  Clinical pharmacokinetics of hypolipidaemic drugs.

Authors:  R Gugler
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

4.  The effects of catecholamines on the distribution of 14C-cholesterol in dogs.

Authors:  J H Gans; M R Cater
Journal:  Lipids       Date:  1969-11       Impact factor: 1.880

5.  The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.

Authors:  G Rodney; P Uhlendorf; R E Maxwell
Journal:  Proc R Soc Med       Date:  1976

6.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

7.  The effects of clofibrate on plasma glucose, lipoproteins, fibrinogen, and other biochemical and haematological variables in patients with mature onset diabetes mellitus.

Authors:  G D Calvert; L Blight; J Franklin; J Oliver; P Wise; A S Gallus
Journal:  Eur J Clin Pharmacol       Date:  1980-05       Impact factor: 2.953

8.  A GLC method for estimation of chlorophenoxyisobutyric acid in plasma. Pharmacokinetics of a single oral dose of clofibrate in man.

Authors:  G Houin; J J Thébault; P D'Athis; J P Tillement; J L Beaumont
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

9.  Branched chain amino acid oxidation in cultured rat skeletal muscle cells. Selective inhibition by clofibric acid.

Authors:  W M Pardridge; D Casanello-Ertl; L Duducgian-Vartavarian
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

10.  Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.

Authors:  B M Wolfe; J P Kane; R J Havel; H P Brewster
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.